Actos Bladder Cancer Victim Seeks $10M in Damages
By Matt O’Donnell
A New York woman has filed a $10 million lawsuit against Takeda Pharmaceuticals alleging the company’s diabetes drug Actos caused her to develop bladder cancer. Her Actos bladder cancer lawsuit is seeking damages for severe permanent injuries, pain, suffering, emotional distress, fear, and to cover her medical expenses for chemotherapy and surgery. Her case joins hundreds of other Actos bladder cancer lawsuits pending in the current Actos multi-district litigation (MDL).Plaintiff Wanda Heavey alleges in the Actos bladder cancer lawsuit that she started using Actos in January 2005 for the treatment of her type II diabetes, and used it as prescribed until about 2010. Heavey was diagnosed with bladder cancer in December 2010, which her Actos lawyer claims was directly caused by taking the diabetes drug. She now fears for her life, and is seeking $10 million in damages from Takeda. Heavey’s original case was filed on June 12, 2012 by her Actos lawyer in the Eastern District of New York, but was transferred to the Actos lawsuit MDL in the Western District of Louisiana on July 12, 2012, where it joins many other Actos bladder cancer lawsuits seeking damages for Actos injuries.
Updated July 30th, 2012
{loadposition content_postads}
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement


